The use of paediatric artemisinin combinations in sub-Saharan Africa: a snapshot questionnaire survey of health care personnel
<p>Abstract</p> <p>Background</p> <p>Paediatric drug formulations for artemisinin combination therapy (P-ACT) have been developed over the past few years and have been shown to improve the therapeutic management of young children with uncomplicated falciparum malaria. T...
Main Authors: | , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-12-01
|
Series: | Malaria Journal |
Subjects: | |
Online Access: | http://www.malariajournal.com/content/10/1/365 |
_version_ | 1818918011190378496 |
---|---|
author | Agnandji Selidji T Kurth Florian Fernandes Jose F Soulanoudjingar Solange S Abossolo Beatrice P Mombo-Ngoma Ghyslain Basra Arti González Raquel Kizito Gondo Mayengue Pembe I Auer-Hackenberg Lorenz Issifou Saadou Lell Bertrand Adegnika Ayola A Ramharter Michael |
author_facet | Agnandji Selidji T Kurth Florian Fernandes Jose F Soulanoudjingar Solange S Abossolo Beatrice P Mombo-Ngoma Ghyslain Basra Arti González Raquel Kizito Gondo Mayengue Pembe I Auer-Hackenberg Lorenz Issifou Saadou Lell Bertrand Adegnika Ayola A Ramharter Michael |
author_sort | Agnandji Selidji T |
collection | DOAJ |
description | <p>Abstract</p> <p>Background</p> <p>Paediatric drug formulations for artemisinin combination therapy (P-ACT) have been developed over the past few years and have been shown to improve the therapeutic management of young children with uncomplicated falciparum malaria. This process was however not equally paralleled by a timely adoption of P-ACT in national and international treatment recommendations. National malaria programmes in sub-Saharan Africa have not yet widely embraced this new therapeutic tool. To which extent P-ACT is used in the field in sub-Saharan Africa is not known to date.</p> <p>Methods</p> <p>This snapshot questionnaire survey aimed to provide an overview on the current routine practices for the availability and use of P-ACT as anti-malarial treatment for young children in sub-Saharan Africa. Health care personnel in seven countries in West-, Central, and East-Africa were invited to answer a structured questionnaire assessing use and availability of P-ACT.</p> <p>Results</p> <p>A total of 71 respondents including doctors, nurses and pharmacy personnel responsible for the anti-malarial treatment of young children were interviewed. P-ACT was used by 83% (95% confidence interval: 73-90%; n = 59) as first-line treatment for young children. Use of 15 different P-ACT products was reported among which only two have received WHO prequalification status and approval by a stringent registration authority. Use of a specific P-ACT product was not linked to consumer prices or availability of supporting clinical trial data, but may depend more on the marketing capacity of the manufacturer. Major differences in frequency and dosing of anti-malarial regimens with identical anti-malarial compounds and the marketing of loose combinations were recorded.</p> <p>Conclusion</p> <p>Paediatric ACT is widely used for the treatment of uncomplicated malaria in young children. However, the majority of P-ACT formulations in use do not meet highest international quality standards evoking concerns for patients' safety and the induction of drug resistance. Improving the quality of currently marketed P-ACT should constitute a public health priority besides their adoption into official treatment recommendations.</p> |
first_indexed | 2024-12-20T00:43:10Z |
format | Article |
id | doaj.art-177617cdcd614c748dcf489432c1f7f3 |
institution | Directory Open Access Journal |
issn | 1475-2875 |
language | English |
last_indexed | 2024-12-20T00:43:10Z |
publishDate | 2011-12-01 |
publisher | BMC |
record_format | Article |
series | Malaria Journal |
spelling | doaj.art-177617cdcd614c748dcf489432c1f7f32022-12-21T19:59:29ZengBMCMalaria Journal1475-28752011-12-0110136510.1186/1475-2875-10-365The use of paediatric artemisinin combinations in sub-Saharan Africa: a snapshot questionnaire survey of health care personnelAgnandji Selidji TKurth FlorianFernandes Jose FSoulanoudjingar Solange SAbossolo Beatrice PMombo-Ngoma GhyslainBasra ArtiGonzález RaquelKizito GondoMayengue Pembe IAuer-Hackenberg LorenzIssifou SaadouLell BertrandAdegnika Ayola ARamharter Michael<p>Abstract</p> <p>Background</p> <p>Paediatric drug formulations for artemisinin combination therapy (P-ACT) have been developed over the past few years and have been shown to improve the therapeutic management of young children with uncomplicated falciparum malaria. This process was however not equally paralleled by a timely adoption of P-ACT in national and international treatment recommendations. National malaria programmes in sub-Saharan Africa have not yet widely embraced this new therapeutic tool. To which extent P-ACT is used in the field in sub-Saharan Africa is not known to date.</p> <p>Methods</p> <p>This snapshot questionnaire survey aimed to provide an overview on the current routine practices for the availability and use of P-ACT as anti-malarial treatment for young children in sub-Saharan Africa. Health care personnel in seven countries in West-, Central, and East-Africa were invited to answer a structured questionnaire assessing use and availability of P-ACT.</p> <p>Results</p> <p>A total of 71 respondents including doctors, nurses and pharmacy personnel responsible for the anti-malarial treatment of young children were interviewed. P-ACT was used by 83% (95% confidence interval: 73-90%; n = 59) as first-line treatment for young children. Use of 15 different P-ACT products was reported among which only two have received WHO prequalification status and approval by a stringent registration authority. Use of a specific P-ACT product was not linked to consumer prices or availability of supporting clinical trial data, but may depend more on the marketing capacity of the manufacturer. Major differences in frequency and dosing of anti-malarial regimens with identical anti-malarial compounds and the marketing of loose combinations were recorded.</p> <p>Conclusion</p> <p>Paediatric ACT is widely used for the treatment of uncomplicated malaria in young children. However, the majority of P-ACT formulations in use do not meet highest international quality standards evoking concerns for patients' safety and the induction of drug resistance. Improving the quality of currently marketed P-ACT should constitute a public health priority besides their adoption into official treatment recommendations.</p>http://www.malariajournal.com/content/10/1/365Artemisinin based combinations therapyPaediatric drug formulationArtemetherLumefantrineAmodiaquineDihydroartemisininPiperaquineMefloquine |
spellingShingle | Agnandji Selidji T Kurth Florian Fernandes Jose F Soulanoudjingar Solange S Abossolo Beatrice P Mombo-Ngoma Ghyslain Basra Arti González Raquel Kizito Gondo Mayengue Pembe I Auer-Hackenberg Lorenz Issifou Saadou Lell Bertrand Adegnika Ayola A Ramharter Michael The use of paediatric artemisinin combinations in sub-Saharan Africa: a snapshot questionnaire survey of health care personnel Malaria Journal Artemisinin based combinations therapy Paediatric drug formulation Artemether Lumefantrine Amodiaquine Dihydroartemisinin Piperaquine Mefloquine |
title | The use of paediatric artemisinin combinations in sub-Saharan Africa: a snapshot questionnaire survey of health care personnel |
title_full | The use of paediatric artemisinin combinations in sub-Saharan Africa: a snapshot questionnaire survey of health care personnel |
title_fullStr | The use of paediatric artemisinin combinations in sub-Saharan Africa: a snapshot questionnaire survey of health care personnel |
title_full_unstemmed | The use of paediatric artemisinin combinations in sub-Saharan Africa: a snapshot questionnaire survey of health care personnel |
title_short | The use of paediatric artemisinin combinations in sub-Saharan Africa: a snapshot questionnaire survey of health care personnel |
title_sort | use of paediatric artemisinin combinations in sub saharan africa a snapshot questionnaire survey of health care personnel |
topic | Artemisinin based combinations therapy Paediatric drug formulation Artemether Lumefantrine Amodiaquine Dihydroartemisinin Piperaquine Mefloquine |
url | http://www.malariajournal.com/content/10/1/365 |
work_keys_str_mv | AT agnandjiselidjit theuseofpaediatricartemisinincombinationsinsubsaharanafricaasnapshotquestionnairesurveyofhealthcarepersonnel AT kurthflorian theuseofpaediatricartemisinincombinationsinsubsaharanafricaasnapshotquestionnairesurveyofhealthcarepersonnel AT fernandesjosef theuseofpaediatricartemisinincombinationsinsubsaharanafricaasnapshotquestionnairesurveyofhealthcarepersonnel AT soulanoudjingarsolanges theuseofpaediatricartemisinincombinationsinsubsaharanafricaasnapshotquestionnairesurveyofhealthcarepersonnel AT abossolobeatricep theuseofpaediatricartemisinincombinationsinsubsaharanafricaasnapshotquestionnairesurveyofhealthcarepersonnel AT mombongomaghyslain theuseofpaediatricartemisinincombinationsinsubsaharanafricaasnapshotquestionnairesurveyofhealthcarepersonnel AT basraarti theuseofpaediatricartemisinincombinationsinsubsaharanafricaasnapshotquestionnairesurveyofhealthcarepersonnel AT gonzalezraquel theuseofpaediatricartemisinincombinationsinsubsaharanafricaasnapshotquestionnairesurveyofhealthcarepersonnel AT kizitogondo theuseofpaediatricartemisinincombinationsinsubsaharanafricaasnapshotquestionnairesurveyofhealthcarepersonnel AT mayenguepembei theuseofpaediatricartemisinincombinationsinsubsaharanafricaasnapshotquestionnairesurveyofhealthcarepersonnel AT auerhackenberglorenz theuseofpaediatricartemisinincombinationsinsubsaharanafricaasnapshotquestionnairesurveyofhealthcarepersonnel AT issifousaadou theuseofpaediatricartemisinincombinationsinsubsaharanafricaasnapshotquestionnairesurveyofhealthcarepersonnel AT lellbertrand theuseofpaediatricartemisinincombinationsinsubsaharanafricaasnapshotquestionnairesurveyofhealthcarepersonnel AT adegnikaayolaa theuseofpaediatricartemisinincombinationsinsubsaharanafricaasnapshotquestionnairesurveyofhealthcarepersonnel AT ramhartermichael theuseofpaediatricartemisinincombinationsinsubsaharanafricaasnapshotquestionnairesurveyofhealthcarepersonnel AT agnandjiselidjit useofpaediatricartemisinincombinationsinsubsaharanafricaasnapshotquestionnairesurveyofhealthcarepersonnel AT kurthflorian useofpaediatricartemisinincombinationsinsubsaharanafricaasnapshotquestionnairesurveyofhealthcarepersonnel AT fernandesjosef useofpaediatricartemisinincombinationsinsubsaharanafricaasnapshotquestionnairesurveyofhealthcarepersonnel AT soulanoudjingarsolanges useofpaediatricartemisinincombinationsinsubsaharanafricaasnapshotquestionnairesurveyofhealthcarepersonnel AT abossolobeatricep useofpaediatricartemisinincombinationsinsubsaharanafricaasnapshotquestionnairesurveyofhealthcarepersonnel AT mombongomaghyslain useofpaediatricartemisinincombinationsinsubsaharanafricaasnapshotquestionnairesurveyofhealthcarepersonnel AT basraarti useofpaediatricartemisinincombinationsinsubsaharanafricaasnapshotquestionnairesurveyofhealthcarepersonnel AT gonzalezraquel useofpaediatricartemisinincombinationsinsubsaharanafricaasnapshotquestionnairesurveyofhealthcarepersonnel AT kizitogondo useofpaediatricartemisinincombinationsinsubsaharanafricaasnapshotquestionnairesurveyofhealthcarepersonnel AT mayenguepembei useofpaediatricartemisinincombinationsinsubsaharanafricaasnapshotquestionnairesurveyofhealthcarepersonnel AT auerhackenberglorenz useofpaediatricartemisinincombinationsinsubsaharanafricaasnapshotquestionnairesurveyofhealthcarepersonnel AT issifousaadou useofpaediatricartemisinincombinationsinsubsaharanafricaasnapshotquestionnairesurveyofhealthcarepersonnel AT lellbertrand useofpaediatricartemisinincombinationsinsubsaharanafricaasnapshotquestionnairesurveyofhealthcarepersonnel AT adegnikaayolaa useofpaediatricartemisinincombinationsinsubsaharanafricaasnapshotquestionnairesurveyofhealthcarepersonnel AT ramhartermichael useofpaediatricartemisinincombinationsinsubsaharanafricaasnapshotquestionnairesurveyofhealthcarepersonnel |